Bill117th CongressFiled Jan 11, 2021Health
H.R. 254
Neuromyelitis Optica Spectrum Disorder Consortium Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jan 11, 2021)
Neuromyelitis Optica Spectrum Disorder Consortium Act
This bill requires the National Institutes of Health to establish a national consortium to coordinate and support research on neuromyelitis optica spectrum disorder, including by awarding grants. This is a neurological disease that can cause blindness, paralysis, and premature death.
What just happenedFeb 2, 2021
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Lee, Barbara [D-CA-13](D-CA)Sponsor
1committees4actions13subjects
- Introduced in HouseJan 11, 2021
- Feb 2, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 11, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 11, 2021IntroReferralIntro-H
Introduced in House
- Jan 11, 2021IntroReferral1000
Introduced in House